ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting
Client Age [clear]
Topic Area [clear]
Experience [clear]
Course Format
SIG
Instructional Level [clear]
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The article in this SIG 6 activity focuses on the audiologic variations seen among patients undergoing the same type of ototoxic drug treatment (cisplatin). Results show a large amount of audiologic outcome variability among the two patients examined, despite similar demographic factors, drug treatments, and types of cancer. Factors relating to ototoxic susceptibility are discussed, and the importance of otoxicity monitoring programs for early detection of audiologic change is highlighted.
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: These SIG 7 Perspectives articles focus on auditory rehabilitation (AR) for adults with cochlear implants. While the benefits of AR in the population are recognized in the literature, service-delivery models are variable, and there is no gold standard approach to developing and implementing a comprehensive AR program. Glade and colleagues provide an overview of clinical models currently being used for the provision of AR for adults with cochlear implants from nine clinics across the country. The article highlights the importance of interprofessional practice in AR and outlines the roles of professionals included on care teams. There is a discussion about barriers to successful implementation of AR programs, including distance to services, and recommendations for potential solutions, such as teletherapy. In the second article, Mosley describes the process of creating and implementing a comprehensive teleaudiology AR program for older adults who use cochlear implants at the University of South Alabama Speech & Hearing Center.
Presenter(s): Shibani S. Mukerji, MD, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session addresses the question of why patients with COVID-19 have such diverse clinical presentations. The speaker zooms in at the microscopic level to explore the nature and frequency of neurologic sequelae of COVID-19, covering findings observed on neuroimaging and cerebrospinal fluid testing. The session summarizes data from neuropathological studies, discusses new studies on the involvement of the peripheral nervous system, and explores treatment considerations.
Presenter(s): Rebecca J Boersma, MA, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session reviews the emerging evidence of neurological manifestations of COVID-19 and identifies how SLPs can use their unique position to maximize patient outcomes-whether as a member of an interdisciplinary team or as a solo provider. The session strives to increase clinicians' confidence in their abilities to: identify common cognitive-communication symptoms for patients who have recovered from COVID-19, and evaluate and treat with an individualized, patient-centered approach.
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: This journal self-study course highlights the impacts of the COVID-19 pandemic on people with aphasia, patients with cognitive communication impairments, and patient-provider communication. The findings can inform decision-making and assist SLPs in optimizing treatment for communication challenges for patients with COVID-19 as well as those for whom treatment has been altered as a result of the pandemic.